Using high-quality administrative data from Upper Austria, we analyze the effect of hospital crowding on patients' short- and medium-term healthcare utilization and labor market outcomes. Focusing on acute inpatient diagnoses, we exploit idiosyncratic variation in daily diagnosis-related...

Background Evidence on the cost effectiveness of deprescribing in multimorbidity is limited. Objective To investigate the cost effectiveness of a general practitioner (GP) delivered, individualised medication review to reduce polypharmacy and potentially inappropriate prescribing in older...

Background As the number of randomized clinical trials (RCTs) demonstrating the survival benefits of combination therapies in previously treated multiple myeloma (MM) patients increases, it is essential to determine the most cost- effective treatment through robust economic evaluation. This...

Recently, public and private providers within two-tier healthcare markets have engaged in a fierce competition for patients, which is significantly influenced by patients' multifaceted sensitivities to delays and payments, particularly when patients' potential balking is considered. However,...

Background: In a world increasingly shaped by technological innovation, the healthcare sector plays an important role in society's sustainable advancement. This study explores the use of IoT and RFID technologies to improve hospital operations and modernize healthcare services. Methods: We...

There is a lack of understanding of what may drive gender disparities in healthcare utilization and outcomes. We present novel evidence on the impact of physician-patient gender match on healthcare quality using standardized patients (SPs) in an experiment, and collected interactions between SPs...

Informal payments in the public health care system represent one of the most sensitive topics in the medical world. It is also a subject of interest for many researchers. As evidenced by reports from various European institutions, a catalyst for their use was the COVID-19 pandemic. Among all the...

The health and medicine sector are increasingly digitized, a trend that will accelerate with more widespread adoption of artificial intelligence, wearables and internet of things-based healthcare. Yet, this digital transformation carries notable cybersecurity threats. While there is ample...

Typically, a Health Technology Assessment (HTA) measures the added value of a new medicine in comparison with the best existing treatment. Patients have direct knowledge on which side effects are manageable, the impact and most relevant factors, and the qualitative meaning of quality-of-life...

The European Cancer Patient Digital Centre (ECPDC) aims at increasing the quality of life of cancer patients and survivors, which is often characterised by a lack of understanding or insufficient consideration of patient needs during and after the treatment. In 2022, the European Commission...

Cross-border healthcare refers to healthcare received by an individual outside of their Member State of affiliation. EU citizens have the right to receive healthcare in any EU country and to be reimbursed for cross-border care by their home country. To guarantee this fundamental right, the EU...

The roadmap for 'Medical Applications of Ionising Radiation for Better Patients' Lives' has been established within the Euratom Horizon 2020 EURAMED rocc-n-roll project. It takes into account the EURAMED rocc-n-roll Strategic Research Agenda (SRA). Based on a patient-centric approach, the...

While physicians are crucial to patient outcomes, what determines physician behavior and decision making remains to be understood. In this paper, we study how physicians' family characteristics influence physicians' behavior and patient health outcomes. Using administrative data from Denmark and...

Home care services have a significant role in lowering healthcare expenditure. Supply chain management in home healthcare (HHC) ensures efficient delivery of medical supplies and equipment to patients' homes, improving overall quality of care and patient outcomes. This study proposes a routing...

Background Atherosclerotic Cardiovascular Disease (ASCVD) is a global public health concern. This study aimed to estimate the healthcare resource utilization (HRU) and costs stratified by cardiovascular disease (CVD) risk categories using real-world evidence, in a regional population in...

Objective To perform a comparison of the measurement properties of two cancer-specific Multi-Attribute Utility Instruments (MAUIs), EORTC QLU-C10D and FACT-8D, in Chinese patients with hematologic malignancies (HM). Methods We conducted a longitudinal study on patients with HM in China, using...

Background Significant gaps in scholarship on the cost-benefit analysis of haemodialysis exist in low-middle- income countries, including Nigeria. The study, therefore, assessed the cost-benefit of haemodialysis compared with comprehensive conservative care (CCC) to determine if haemodialysis is...

Can information about the value of diagnostic tests improve provider practice and help patients recognize higher quality of care In a randomized experiment at public clinics in Mali, health providers and patients received tailored information about the importance of rapid diagnostic tests (RDTs)...

Background & aim Hepatitis B is globally recognized as a major public health problem that imposes a huge economic burden on society. China is a major country with hepatitis B infection; however, an updated overview of the economic burden of hepatitis B and related diseases in China has not been...